I commend to your attention how you may help DSM employees and their children who suffer from autoimmune diseases such as Lupus, MS, Type 1 Diabetes, plaque psoriasis, and rheumatoid arthritis etc by helping to promote the use of and easy accessibility of BCG in the US. See eg pubmed.org faustma dl, pubmed.org ristori + BCG and faustmanlab.org. As you may know TB is becoming more common in the US. BCG is safe for even pregnant women. See below.
>>> Rigshospitalet <news@meltwaterpress.com> 9/3/2012 9:27 AM >>>
 Press release |
||
3rd of September 2012 |
||
Tuberculosis vaccine - a new remedy for allergies and asthma in children? M Can a vaccine against tuberculosis help combat asthma and eczema in Danish children early in life? This will now be examined in a comprehensive Danish research study. From September 2012, thousands of Danish pregnant women will receive an invitation to allow their newborns to take part in a sensational trial. The tuberculosis vaccine was removed from the vaccine program in Denmark during the 1980s, however new research indicates that the vaccine can improve the health of children. Research carried out in developing countries shows that the health of infants who have been given the tuberculosis vaccine (BCG/Calmette) at birth is improved and the babies have a better survival rate than those who have not been given the vaccine. The vaccine also seems to have a preventive effect against asthma and atopic dermatitis. Results are so striking that they cannot be explained by the fact that the children did not catch tuberculosis. Therefore, researchers assess the vaccine to have a general positive effect on the immune system, which means that children are less sick, and have less atopic dermatitis, asthma and allergies. Whether this positive effect also can benefit Danish children will now be examined in a large Danish research project headed by Lone Graff Stensballe, Paediatrician from the Department of Paediatrics and Adolescent Medicine at Rigshospitalet. The research project will run for three years, starting in September 2012, where 4,300 infants and their parents will be followed through interviews, examinations, and, for 300 of the children, blood tests as well. The project will comprise five PhD courses and a research collaboration with obstetricians, paediatricians, midwives, nurses and laboratory technicians from the three hospitals taking part in the project. “We are very excited about this unique opportunity to improve the health of Danish children early in life,” says Lone Graff Stensballe. “Unfortunately, we have seen large increases in admissions, consumption of medicines, asthma, eczema and allergies among Danish children. We hope to curb these increases with the new research project.” The research project will be carried out at Rigshospitalet in collaboration with Hvidovre Hospital, Kolding Sygehus Lillebælt and the new Centre for Vitamins and Vaccines at SSI (Statens Serum Institut). For further information and interviews, please contact: Lone Graff Stensballe Head of Research Paediatrician, Department of Paediatrics and Adolescent Medicine, Rigshospitalet, Denmark Telephone: +45 6022 8092 E-mail: lone.graff.stensballe@rh.regionh.dk |
||
|
||
Afmelding: Ønsker du ikke længere at få tilsendt e-mails fra Rigshospitalet via Meltwater Press, venligst klik: [her]. Afmelding kan tage op til 2 arbejdsdage.
Hvis du ønsker at kontakte Meltwater Press, kan du kontakte Meltwater Press på:
Meltwater Group Christian IX's Gade 10, 2. 1111 København K
--------------------------------------------------------
The information transmitted in this email and any of its attachments is intended only for the person or entity to which it is addressed and may contain information concerning Cablevision and/or its affiliates and subsidiaries that is proprietary, privileged, confidential and/or subject to copyright. Any review, retransmission, dissemination or other use of, or taking of any action in reliance upon, this information by persons or entities other than the intended recipient(s) is prohibited and may be unlawful. If you received this in error, please contact the sender immediately and delete and destroy the communication and all of the attachments you have received and all copies thereof.
--------------------------------------------------------
Denne e-mail indeholder fortrolig information. Hvis du ikke er den rette modtager af denne e-mail eller hvis du modtager den ved en fejltagelse, beder vi dig venligst informere afsender om fejlen ved at bruge svarfunktionen. Samtidig bedes du slette e-mailen med det samme uden at videresende eller kopiere den.
Ristori
G, Romano S, Cannoni S, Visconti A, Tinelli E, Mendozzi L, Cecconi P,
Lanzillo R, Quarantelli M, Buttinelli C, Gasperini C, Frontoni M,
Coarelli G, Caputo D, Bresciamorra V, Vanacore N, Pozzilli C, Salvetti
M.
Neurology. 2014 Jan 7;82(1):41-8. doi: 10.1212/01.wnl.0000438216.93319.ab. Epub 2013 Dec 4.
- PMID:
- 24306002
- [PubMed - indexed for MEDLINE]
Immunobiology
Laboratory Denise
Faustman, MD, PhD
Massachusetts General Hospital
East Director,
Immunobiology Laboratory
Building 149, Thirteenth Street, Room
3601
Associate Professor of Medicine
Charlestown, Massachusetts
02129 Harvard
Medical School
Tel: 617-726-4084
Fax: 617-726-4095
August
12, 2014
Dear
Friends,
We are
recruiting patients who:
- are over 18 years old; and
- have had type 1 diabetes for less than 20 years.
If you
are interested and fit this criteria please call
617-726-4084 or email
diabetestrial@partners.org
(Subject
line: Faustman Lab Research Interest). For new patients and
those that have not donated blood
samples
to the Faustman lab in over a year, we will schedule you for
a 30 minute screening visit to
donate
a blood sample at our facility in Boston. Data collected
may be used for eligibility screening for
proposed
Phase II studies testing the BCG vaccine as a treatment for
type 1 diabetes.
Patients
from all over the world are welcome to participate in our
research, though future studies may
require
frequent visits to our lab in Boston.
You may also visit our website at
www.faustmanlab.org to
learn
more about our research.
Thank
you again for your continued support!
Sincerely,
Denise
L. Faustman, MD, PhD
The information in this e-mail is intended only for the person
to whom it is
addressed. If you believe this e-mail was sent to you in error and the e-mail
contains patient information, please contact the Partners Compliance HelpLine at
http://www.partners.org/complianceline . If the e-mail was sent to you in error
but does not contain patient information, please contact the sender and properly
dispose of the e-mail.
addressed. If you believe this e-mail was sent to you in error and the e-mail
contains patient information, please contact the Partners Compliance HelpLine at
http://www.partners.org/complianceline . If the e-mail was sent to you in error
but does not contain patient information, please contact the sender and properly
dispose of the e-mail.
Immunobiology
Laboratory Denise
Faustman, MD, PhD
Massachusetts
General Hospital
East
Director, Immunobiology Laboratory
Building 149, Thirteenth Street, Room 3601
Associate Professor of Medicine
Charlestown,
Massachusetts
02129
Harvard Medical School
Tel: 617-726-4084
Fax: 617-726-4095
August 12, 2014
Dear Friends,
We are recruiting patients who:
- are over 18 years old; and
- have had type 1 diabetes for less than 20 years.
If you are interested and fit this criteria please call 617-726-4084 or email
diabetestrial@partners.org
(Subject line: Faustman Lab Research Interest). For new patients and those that have not donated blood
samples to the Faustman lab in over a year, we will schedule you for a 30 minute screening visit to
donate a blood sample at our facility in Boston. Data collected may be used for eligibility screening for
proposed Phase II studies testing the BCG vaccine as a treatment for type 1 diabetes.
Patients from all over the world are welcome to participate in our research, though future studies may
require frequent visits to our lab in Boston.
You may also visit our website at
www.faustmanlab.org to
learn more about our research.
Thank you again for your continued support!
Sincerely,
Denise L. Faustman, MD, PhD
The information in this e-mail is intended only for the person to whom it is
addressed. If you believe this e-mail was sent to you in error and the e-mail
contains patient information, please contact the Partners Compliance HelpLine at
http://www.partners.org/complianceline . If the e-mail was sent to you in error
but does not contain patient information, please contact the sender and properly
dispose of the e-mail.
addressed. If you believe this e-mail was sent to you in error and the e-mail
contains patient information, please contact the Partners Compliance HelpLine at
http://www.partners.org/complianceline . If the e-mail was sent to you in error
but does not contain patient information, please contact the sender and properly
dispose of the e-mail.
Subject:
Faustman Program: Type 1 Diabetes Recruitment |
From:
"Murphy, Lynne" <LMURPHY1@mgh.harvard.edu> |
Date:
8/12/2014 3:56 PM |
To:
|
Immunobiology
Laboratory Denise
Faustman, MD, PhD
Massachusetts
General Hospital
East
Director, Immunobiology Laboratory
Building 149, Thirteenth Street, Room 3601
Associate Professor of Medicine
Charlestown,
Massachusetts
02129
Harvard Medical School
Tel: 617-726-4084
Fax: 617-726-4095
August 12, 2014
Dear Friends,
We are recruiting patients who:
- are over 18 years old; and
- have had type 1 diabetes for less than 20 years.
If you are interested and fit this criteria please call 617-726-4084 or email
diabetestrial@partners.org
(Subject line: Faustman Lab Research Interest). For new patients and those that have not donated blood
samples to the Faustman lab in over a year, we will schedule you for a 30 minute screening visit to
donate a blood sample at our facility in Boston. Data collected may be used for eligibility screening for
proposed Phase II studies testing the BCG vaccine as a treatment for type 1 diabetes.
Patients from all over the world are welcome to participate in our research, though future studies may
require frequent visits to our lab in Boston.
You may also visit our website at
www.faustmanlab.org to
learn more about our research.
Thank you again for your continued support!
Sincerely,
Denise L. Faustman, MD, PhD
addressed. If you believe this e-mail was sent to you in error and the e-mail
contains patient information, please contact the Partners Compliance HelpLine at
http://www.partners.org/complianceline . If the e-mail was sent to you in error
but does not contain patient information, please contact the sender and properly
dispose of the e-mail.
Employees' Children Give Company an Earful on Social Causes
Prompt Royal DSM to Donate to African Countries
Sept. 3, 2014 6:55 p.m. ET
The DSM Kids group helped prompt the company to donate solar stoves to Africa.
Cassie Witte
Corporate PowerPoint presentations aren't usually something to write home about. But
Hugh Welsh,
president of
Royal DSM's
RDSMY -1.49%
North American operations, can't forget a particular presentation at a workplace lunch gathering a couple of years ago.
"It
was actually, from a technical perspective, the greatest presentation
I've ever seen," Mr. Welsh said. He recalls the embedded video and music
track. At one point, the presenter brought up a live-chat session with
an expert in a remote location.
The
creators weren't from Mr. Welsh's executive team, based in Parsippany,
N.J. Instead, they were a group of middle and high schoolers—children of
DSM employees—who had been meeting for months to find ways to encourage
the company to address social causes, especially in underdeveloped
parts of the world.
"I wanted to hire some of them on the spot," Mr. Welsh said.
Royal
DSM, a Netherlands-based conglomerate, has operations in food and
nutrition, energy generation, industrial manufacturing and many other
products around the world. The group of youngsters, known as DSM Kids,
came together in 2011 following Take Our Daughters and Sons to Work Day,
an event many companies nationwide hold annually.
The
PowerPoint presentation that wowed Mr. Welsh was about ways DSM could
help promote education of children and women in underdeveloped parts of
the world. Mr. Welsh said he learned that in some developing countries
girls might not go to school because they have to spend their days
gathering firewood for cooking.
As a
result, DSM donated solar cooking stoves to schools in sub-Saharan
Africa, including Malawi and Kenya, to allow more girls to attend
school, Mr. Welsh said. He said the company continues to focus on issues
of education for women and girls. "A lot of these ideas were sort of
triggered by, believe it or not, these kids," he said.
DSM
Kids, which has 10 participants, operates essentially on its own,
though Mr. Welsh assigned a corporate affairs manager at the company to
"sort of chaperone." The group generally meets on Saturdays at 9 a.m. at
the company's New Jersey office.
"We
got to go in a big conference room with big chairs and a big table and a
microphone and a big screen," said Cassie Witte, 16 years old, whose
mother, Marion, works in human resources at DSM. "It was like, 'Wow, I'm
in an office.' "
Cassie, a high-school
junior in Mount Olive, N.J., said she doesn't mind waking up early on
weekends to participate in something she feels strongly about. But as
the teens have gotten older, school commitments sometimes took priority.
"We slowed down throughout the [last] school year because we had finals
and tests," Cassie said of the group's meetings.
This year, Cassie said DSM Kids plans to focus on food shortages in the U.S. and malnutrition in underdeveloped countries.
The
group also hopes to expand its membership to include children of DSM
employees around the world. And, now that the group's founding members
are getting older, it wants to encourage younger members to join.
Cassie
said TV screens around the DSM office have featured photos of the group
and information about its goals and work, helping to broaden its
exposure to DSM employees.
The company
seeks other feedback from the group. Mr. Welsh said he periodically asks
what they think of their parents' work schedule. Their responses helped
prompt DSM to implement flexible summer hours and remote working, he
said.
The youngsters' multimedia skills
also are in demand. Mr. Welsh said some senior administrative assistants
approached the group after its PowerPoint presentation, trying to
garner tips for when their bosses might ask them to match the kids'
jazzy presentation skills.
"I have some executives that are proud of themselves because they can use color in their PowerPoints," Mr. Welsh said.
Write to Rachel Feintzeig at rachel.feintzeig@wsj.com
No comments:
Post a Comment